Dermatology

Combining ixekizumab with tirzepatide improved skin clearance and weight loss in adults with psoriasis and obesity in a Phase 3b trial.

New trial data show dupilumab improves itch, skin healing and quality of life in patients with prurigo nodularis, even without optimal response.

English registry data show lentigo maligna has only a 1% risk of progression to invasive melanoma over 10 years.

Tildrakizumab showed sustained efficacy and safety in moderate-to-severe scalp psoriasis, regardless of obesity status, over 52 weeks.

A real-world study found tildrakizumab improved skin clearance, symptoms, and quality of life in adults with plaque psoriasis.

A large BADBIR study assesses serious infection risk across psoriasis systemic treatments, highlighting largely similar safety profiles with some treatment-specific signals.

High-potency and long-term topical corticosteroid use may increase type 2 diabetes risk, according to a large nationwide cohort study.

COVID-19 disrupted melanoma diagnoses, reducing early detection and shifting prognostic patterns across regions with different public health strategies.